Lentivirus-GPVI mab (BGF2) WT Cas9-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR7)

The product is a highly efficient, inducible WT Cas9-ASGR1 gene-editing based novel Lentivirus packaging system that can be used to mediate researches involving anti-GPVI mab (BGF2) in Human B cell engineering.

Datasheet

Specifications

Clone BGF2
Host Humanized
Packaging Cell Line HEK 293
Vector Promoter CMV
Rep Rep68
Capsid VP2
Envelope VSV-G
Matrix N-terminal
Size ~24kb
Genome ssRNA
Virus Type Lentivirus
Cofactor Requirement No dNTPs
Particles/mL 9.6 × 10¹¹
PFU/mL 1.7 × 10¹¹
TU/mL 3.3 × 10¹¹
Cas9 WT Cas9
sgRNA ASGR1
Engineered B Cell Human B cells

Target Information

Target GPVI
Alternative Names GPVI

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products